Search by Drug Name or NDC

    NDC 69097-0905-67 Decitabine 50 mg/10mL Details

    Decitabine 50 mg/10mL

    Decitabine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is DECITABINE.

    Product Information

    NDC 69097-0905
    Product ID 69097-905_320d4f65-fe3b-4b9b-a504-98302ebd56b5
    Associated GPIs 21300015002120
    GCN Sequence Number 060839
    GCN Sequence Number Description decitabine VIAL 50 MG INTRAVEN
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 27027
    HICL Sequence Number 033712
    HICL Sequence Number Description DECITABINE
    Brand/Generic Generic
    Proprietary Name Decitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Decitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/10mL
    Substance Name DECITABINE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205539
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0905-67 (69097090567)

    NDC Package Code 69097-905-67
    Billing NDC 69097090567
    Package 1 VIAL, SINGLE-USE in 1 CARTON (69097-905-67) / 10 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2021-09-17
    NDC Exclude Flag N
    Pricing Information N/A